Stockscreener 앱 받기
114.49
3.24%
-3.83
시간 외 거래:
114.49
전일 마감가:
$118.32
열려 있는:
$118.11
하루 거래량:
1.84M
Relative Volume:
1.66
시가총액:
$12.29B
수익:
$769.10M
순이익/손실:
$46.67M
주가수익비율:
327.11
EPS:
0.35
순현금흐름:
$119.79M
1주 성능:
+20.06%
1개월 성능:
+31.67%
6개월 성능:
+187.16%
1년 성능:
+70.45%
1일 변동 폭
$111.79
$118.53
1주일 범위
$90.00
$122.21
52주 변동 폭
$28.66
$122.21
코르셉트 테라퓨틱스 Stock (CORT) Company Profile
명칭
Corcept Therapeutics Inc
전화
650.688.8803
주소
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Compare CORT vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CORT
Corcept Therapeutics Inc
|
114.49 | 9.78B | 769.10M | 46.67M | 119.79M | 0.35 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
코르셉트 테라퓨틱스 Stock (CORT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-05-13 | 업그레이드 | UBS | Neutral → Buy |
| 2026-03-26 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2025-12-31 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2025-12-16 | 개시 | UBS | Neutral |
| 2025-11-18 | 개시 | Wolfe Research | Peer Perform |
| 2023-11-06 | 업그레이드 | Truist | Hold → Buy |
| 2023-04-11 | 개시 | SVB Securities | Market Perform |
| 2023-04-04 | 개시 | Piper Sandler | Overweight |
| 2023-02-15 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-08-01 | 다운그레이드 | Truist | Buy → Hold |
| 2022-07-27 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-06-27 | 재개 | Canaccord Genuity | Buy |
| 2022-02-02 | 개시 | Canaccord Genuity | Buy |
| 2022-01-28 | 개시 | Truist | Buy |
| 2020-08-05 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-09-24 | 개시 | Jefferies | Buy |
| 2019-09-06 | 개시 | H.C. Wainwright | Buy |
| 2019-02-04 | 다운그레이드 | B. Riley FBR | Buy → Neutral |
| 2018-08-10 | 재확인 | Stifel | Hold |
| 2018-05-31 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-03-09 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-08-31 | 개시 | Stifel | Buy |
| 2017-02-02 | 개시 | Ladenburg Thalmann | Buy |
| 2015-04-21 | 개시 | FBR Capital | Outperform |
| 2014-01-13 | 다운그레이드 | Stifel | Buy → Hold |
| 2013-08-09 | 다운그레이드 | Janney | Buy → Neutral |
| 2013-08-09 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2012-02-21 | 재확인 | JMP Securities | Mkt Outperform |
| 2010-01-06 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2008-07-17 | 개시 | Rodman & Renshaw | Mkt Outperform |
| 2007-06-21 | 업그레이드 | Punk, Ziegel & Co | Mkt Perform → Accumulate |
모두보기
코르셉트 테라퓨틱스 주식(CORT)의 최신 뉴스
CORT|Corcept Therapeutics Inc|Price:91.090|Chg%:-4.270 - TradingKey
Corcept Therapeutics Inc (CORT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
This Warner Bros Discovery Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday - Benzinga
Wolfe Research downgrades Corcept stock on valuation concerns By Investing.com - Investing.com Canada
Corcept Therapeutics (CORT) Lifted Earnings Outlook, Is The Stock Now Overvalued? - Yahoo Finance UK
Corcept Therapeutics (CORT) Is Up 5.3% After Analysts Lift Full-Year Earnings Outlook Significantly - Yahoo Finance UK
Corcept Therapeutics Inc (CORT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Corcept Therapeutics Inc (CORT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Corcept Therapeutics Inc (CORT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Corcept Therapeutics Inc (CORT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
WDC: Western Digital Corp. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Corcept Therapeutics Inc (CORT) Fundamental & Financial Data - Stocktwits
CORT: Corcept Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Corcept Therapeutics And 2 Other Growth Stocks With Significant Insider Ownership - simplywall.st
Corcept Therapeutics to announce Q2 results on July 29 - scanx.trade
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call - Yahoo Finance
Corcept Therapeutics stock hits 52-week high at 95.18 USD By Investing.com - Investing.com Canada
Trump Disclosure Shows Corcept Buy Before FDA Approval - Moomoo
CORT Stock Skyrockets 35% After Early FDA Nod For Ovarian Cancer Drug - Stocktwits
CORT Stock Slips After-Hours On Weak Q4 Print: Retail Is Watching April FDA Meeting For Relacorilant As Next Catalyst - Stocktwits
Corcept Therapeutics(CORT.US) Officer Sells US$3.51 Million in Common Stock - Moomoo
Corcept Therapeutics CFO Mokari sells $3.5m in shares By Investing.com - Investing.com South Africa
Corcept Therapeutics CFO Mokari sells $3.5m in shares - Investing.com
Corcept Therapeutics director Wilson sells $882,985 in common stock By Investing.com - Investing.com Nigeria
Form 4 Corcept Therapeutics Incorporated For: 17 July By Investing.com - Investing.com Canada
Corcept Therapeutics (CORT) director logs 10,000-share indirect sale under 10b5-1 plan - Stock Titan
Corcept Therapeutics (CORT) CFO sells 40,000 shares and exercises options - Stock Titan
Corcept Insider Sells Shares After an FDA Approval and a $1.05 Billion Outlook - Yahoo Finance
Corcept Insider Sells Shares After an FDA Approval and a $1.05 Billion Outlook - The Motley Fool
Corcept Therapeutics Inc (NASDAQ:CORT) Shows Strong Growth Fundamentals and Technical Breakout Setup - ChartMill
CORT Stock Hits Highest Levels In 2026 – Cushing’s Syndrome Drug NDA Resubmission Extends 5-Session Rally - Stocktwits
Fed. Circ. Won't Rethink Corcept Patent Loss In Teva Case - Law360
Corcept Therapeutics: Recent Relacorilant Rejection Aside, A Good News Story For Investors - Seeking Alpha
Corcept Therapeutics : CORT - 24/7 Wall St.
CCORF Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $135 - Moomoo
Form 4 Corcept Therapeutics Incorporated For: 8 July By Investing.com - Investing.com Nigeria
Corcept (NASDAQ: CORT) CBO reports 600-share stock gift and holdings - Stock Titan
Corcept Therapeutics CDO William Guyer sells $1.86m in stock - Investing.com
Corcept Therapeutics CDO William Guyer sells $1.86m in stock By Investing.com - Investing.com India
Insider at Corcept (NASDAQ: CORT) sells shares after option exercise - Stock Titan
Form 144 CORCEPT THERAPEUTICS INC For: 7 July By Investing.com - Investing.com Nigeria
William Guyer to sell 20,000 CORT shares (NASDAQ: CORT) via option exercise - Stock Titan
Corcept Therapeutics highlights its endocrine focus as investors watch CORT stock - AD HOC NEWS
CORT News | CORCEPT THERAPEUTICS INC (NASDAQ:CORT) - ChartMill
Corcept (CORT) executive sells 25K shares after exercising options - Stock Titan
CORTCorcept Therapeutics Inc Options - Finviz
Corcept Therapeutics stock hits 52-week high at 91.1 USD By Investing.com - Investing.com Canada
Healthcare Stocks Investors Are Turning To After The Weak US Jobs Report - Sahm
코르셉트 테라퓨틱스 (CORT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
코르셉트 테라퓨틱스 주식 (CORT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| WILSON JAMES N | Director |
Jul 15 '26 |
Sale |
88.30 |
10,000 |
882,986 |
1,084,543 |
| Mokari Atabak | Chief Financial Officer |
Jul 15 '26 |
Option Exercise |
21.56 |
40,000 |
862,235 |
56,130 |
| Mokari Atabak | Chief Financial Officer |
Jul 15 '26 |
Sale |
87.71 |
40,000 |
3,508,277 |
16,130 |
| Guyer William | Chief Development Officer |
Jul 07 '26 |
Option Exercise |
21.65 |
20,000 |
433,000 |
23,985 |
| Guyer William | Chief Development Officer |
Jul 07 '26 |
Sale |
93.13 |
20,000 |
1,862,530 |
3,985 |
2.44%
0.02%
자본화:
|
볼륨(24시간):